HFM
UTHR icon

Harvest Fund Management’s United Therapeutics UTHR Stock Holding History

Harvest Fund Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Hold
314
– – 0.01% 278
2026
Q1 		$186K Sell
314
-2,379
-88% -$1.18M 0.01% 285
2025
Q4 		$949K Hold
2,693
– – 0.04% 192
2025
Q3 		$949K Hold
2,693
– – 0.04% 195
2025
Q2 		$949K Hold
2,693
– – 0.04% 189
2025
Q1 		$949K Hold
2,693
– – 0.05% 202
2024
Q4 		$949K Buy
2,693
+2,021
+301% +$743K 0.04% 227
2024
Q3 		$241K Sell
672
-508
-43% -$172K 0.01% 323
2024
Q2 		$376K Buy
+1,180
New +$312K 0.03% 266
2021
Q4 		– Sell
-159
Closed -$29K – 812
2021
Q3 		$29K Buy
+159
New +$31.3K 0.01% 539

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Harvest Fund Management's UTHR Position: Q2 2026 in Review

Harvest Fund Management held its United Therapeutics (UTHR) position steady in Q2 2026 at 314 shares worth $170K. The position accounts for 0.01% of the portfolio, ranked #278.

Harvest Fund Management first reported a position in UTHR in Q3 2021 and has held it in 10 quarters since. The position peaked at $949K in Q4 2025. 878 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Harvest Fund Management held 314 shares of United Therapeutics worth $170K as of Q2 2026.
  • Harvest Fund Management left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up 0.01% of Harvest Fund Management's portfolio in Q2 2026, its #278 holding.
  • Harvest Fund Management first reported a position in United Therapeutics in Q3 2021 and has held it in 10 quarters since.
  • Harvest Fund Management's United Therapeutics position peaked at $949K in Q4 2025.
  • 878 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Harvest Fund Management's 13F filing for Q2 2026, filed 20 Aug 2026.